12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Company News  |  Deals

Xencor, Merck deal

Xencor will grant Merck non-exclusive rights to a patent covering Fc engineering methods for use in an undisclosed therapeutic...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >